Wyeth Wins Round 2 In Trio Of Fen-Phen Suits

Law360, New York (July 28, 2010, 3:03 PM EDT) -- For the second time this week a state appeals court has affirmed the dismissal of a suit over Wyeth Inc.'s fen-phen, this time finding that the plaintiff could not prove causation because she did not actually suffer from one of the drug's nondisclosed risks.

In a ruling Tuesday, the Superior Court of Pennsylvania held that Pennsylvania law does not allow a plaintiff to prove proximate causation where a drug manufacturer’s warning disclosed a risk of injury and the plaintiff sustained that very injury, but the manufacturer...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.